News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
94,362 Results
Type
Article (6893)
Company Profile (39)
Press Release (87430)
Section
Business (28228)
Career Advice (127)
Deals (4087)
Drug Delivery (32)
Drug Development (14377)
Employer Resources (12)
FDA (2894)
Job Trends (2130)
News (50078)
Policy (6126)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (431)
Accelerated approval (2)
Adcomms (7)
Allergies (30)
Alliances (9191)
ALS (13)
Alzheimer's disease (267)
Antibody-drug conjugate (ADC) (39)
Approvals (2895)
Artificial intelligence (40)
Autoimmune disease (8)
Automation (3)
Bankruptcy (19)
Best Places to Work (1815)
BIOSECURE Act (16)
Biosimilars (74)
Biotechnology (26)
Bladder cancer (20)
Brain cancer (6)
Breast cancer (51)
Cancer (437)
Cardiovascular disease (20)
Career advice (111)
Career pathing (3)
CAR-T (20)
Cell therapy (84)
Cervical cancer (3)
Clinical research (11682)
Collaboration (182)
Compensation (41)
Complete response letters (9)
COVID-19 (622)
CRISPR (5)
C-suite (48)
Cystic fibrosis (13)
Data (422)
Denatured (2)
Depression (5)
Diabetes (35)
Diagnostics (582)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (23)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (25)
Earnings (9681)
Editorial (6)
Employer branding (3)
Employer resources (10)
Events (12001)
Executive appointments (114)
FDA (3222)
Featured Employer (9)
Frontotemporal dementia (1)
Funding (141)
Gene editing (24)
Generative AI (5)
Gene therapy (79)
GLP-1 (110)
Government (1343)
Grass and pollen (1)
Guidances (11)
Healthcare (1997)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (37)
Indications (8)
Infectious disease (655)
Inflammatory bowel disease (46)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (11)
Interviews (11)
IPO (1877)
IRA (13)
Job creations (387)
Job search strategy (107)
Kidney cancer (2)
Labor market (2)
Layoffs (55)
Leadership (1)
Legal (582)
Liver cancer (13)
Lung cancer (73)
Lymphoma (25)
Management (2)
Manufacturing (99)
MASH (11)
Medical device (1193)
Medtech (1194)
Mergers & acquisitions (2302)
Metabolic disorders (83)
Multiple sclerosis (18)
NASH (2)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (341)
NextGen: Class of 2025 (703)
Non-profit (349)
Northern California (466)
Now hiring (10)
Obesity (30)
Opinion (45)
Ovarian cancer (20)
Pain (8)
Pancreatic cancer (13)
Parkinson's disease (9)
Partnered (3)
Patents (29)
Patient recruitment (19)
Peanut (21)
People (8064)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (3839)
Phase II (4868)
Phase III (4310)
Pipeline (286)
Podcasts (6)
Policy (41)
Postmarket research (302)
Preclinical (1499)
Press Release (66)
Prostate cancer (16)
Psychedelics (5)
Radiopharmaceuticals (37)
Rare diseases (69)
Real estate (934)
Recruiting (4)
Regulatory (4837)
Reports (11)
Research institute (397)
Resumes & cover letters (11)
RNA editing (1)
RSV (10)
Schizophrenia (11)
Series A (33)
Series B (13)
Service/supplier (3)
Sickle cell disease (7)
Southern California (471)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (581)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (2)
The Weekly (4)
United States (4023)
Vaccines (195)
Venture capitalists (4)
Webinars (1)
Weight loss (14)
Women's health (3)
Date
Last 7 days (127)
Last 30 days (511)
Last 365 days (6337)
2025 (1663)
2024 (6547)
2023 (7032)
2022 (9178)
2021 (9597)
2020 (8316)
2019 (5968)
2018 (4594)
2017 (5126)
2016 (4688)
2015 (5350)
2014 (3777)
2013 (2947)
2012 (3048)
2011 (3246)
2010 (2639)
Location
Africa (93)
Alabama (11)
Alaska (1)
Arizona (12)
Arkansas (2)
Asia (8379)
Australia (885)
California (1105)
Canada (229)
China (172)
Colorado (32)
Connecticut (25)
Delaware (37)
Europe (13990)
Florida (128)
Georgia (18)
Idaho (13)
Illinois (46)
India (11)
Indiana (39)
Iowa (1)
Japan (27)
Kansas (3)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (314)
Massachusetts (763)
Michigan (23)
Minnesota (44)
Mississippi (1)
Missouri (14)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (440)
New Mexico (4)
New York (316)
North Carolina (193)
North Dakota (7)
Northern California (466)
Ohio (39)
Oklahoma (7)
Oregon (2)
Pennsylvania (186)
Puerto Rico (1)
Rhode Island (5)
South America (137)
South Carolina (2)
Southern California (471)
Tennessee (3)
Texas (145)
Utah (24)
Virginia (16)
Washington D.C. (6)
Washington State (87)
Wisconsin (7)
94,362 Results for "sino biological".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV
March 10, 2025
·
4 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Deals
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in...
April 26, 2024
·
4 min read
Business
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc.
March 14, 2024
·
3 min read
Press Releases
Sino Biological and BioGeometry Deepen Strategic Cooperation to Empower Protein R&D with Generative AI
September 12, 2024
·
4 min read
Business
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
October 9, 2023
·
3 min read
InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy
Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields
June 5, 2024
·
3 min read
Business
Sino Biological Announces Construction of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing at its Levit Green facility in Houston, Texas USA.
November 21, 2022
·
4 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
1 of 9,437
Next
